HCPCS Code J3360: Diazepam injection billing guide

Key takeaways

HCPCS Code J3360 describes injection of diazepam, up to 5 mg, billed per 5 mg unit under Medicare Part B.

Medicare reimburses J3360 at Average Sales Price plus 6% (ASP+6%). Rates update quarterly via CMS and should be verified before billing.

JW has been mandatory for applicable Medicare drug waste claims since January 1, 2017, and JZ became mandatory on July 1, 2023.

Practice management software like Pabau supports injectable-drug documentation and charge capture, keeping dose, NDC, and diagnosis details together at the point of care.

HCPCS Code J3360: Definition, description, and code details

HCPCS Code J3360 is the billing code for an injection of diazepam, up to 5 mg. A provider gives it in an office, outpatient, or emergency setting. Medicare Part B and commercial payers reimburse it under the Average Sales Price methodology.

Most claim denials for injectable diazepam trace back to one of three errors: the wrong unit count, a missing JW/JZ modifier, or an unsupported diagnosis. This guide covers the code definition, Medicare pricing, and modifier rules. It also covers the NDC crosswalk, covered ICD-10 diagnoses, and the buy-and-bill workflow, so billers and coders have everything in one place.

Diazepam (brand name Valium) is a benzodiazepine used for anxiety management, seizure control, muscle relaxation, and procedural sedation. Because it is a DEA Schedule IV controlled substance, practices must maintain DEA-compliant prescribing and dispensing records in addition to standard claim documentation. The injectable formulation billed under HCPCS Code J3360 is distinct from oral diazepam, which uses a different code series.

According to the Centers for Medicare and Medicaid Services (CMS), HCPCS Level II J-codes cover injectable drugs administered by a provider. They are typically given in an outpatient setting rather than dispensed for self-administration.

Medicare fee schedule and reimbursement rates for J3360

Medicare reimburses HCPCS Code J3360 using the Average Sales Price (ASP) methodology. Under this model, the payment rate is typically ASP plus 6%, covering both the drug cost and a handling allowance. Rates update quarterly based on manufacturer-reported ASP data submitted to CMS.

Important note on specific dollar figures: Because ASP rates change every quarter, publishing fixed reimbursement amounts here would quickly become inaccurate. Always verify the current rate directly from the CMS Physician Fee Schedule lookup tool or the quarterly CMS ASP Drug Pricing file before submitting claims.

Practices in lower-cost rural areas may see MAC-adjusted rates that differ from national averages. Check with your regional Medicare Administrative Contractor for any local coverage determinations (LCDs) that apply to diazepam injection claims in your jurisdiction.

Billing guidelines for HCPCS Code J3360

Clean claim submission for HCPCS Code J3360 depends on accurate unit reporting, correct place of service coding, and complete documentation of the clinical indication. Missing any one of these elements is enough for a MAC to deny or pend the claim.

For practices that administer injectable diazepam regularly, following IV therapy billing practices provides a useful framework for charge capture and documentation. These workflows apply equally to benzodiazepine injections.

• Unit calculation: 1 unit = up to 5 mg. If you administer 10 mg, bill 2 units. Partial doses round up to the next whole unit, so 7 mg is also billed as 2 units.
• NDC reporting: Include the National Drug Code on the claim line. CMS expects NDC reporting on Part B drug claims; Medicaid has separate mandatory NDC requirements. Report as: N4 + 11-digit NDC + unit qualifier (UN for units, ML for milliliters) + quantity administered.
• Place of service: Use the appropriate POS code for where the injection was administered (see POS section below).
• Diagnosis linkage: The claim must carry at least one ICD-10 diagnosis code that supports medical necessity for diazepam injection.
• Drug waste modifiers: JW or JZ modifier required on every applicable Medicare claim (see modifier section below).
• Controlled substance documentation: Maintain DEA-compliant records including prescriber DEA registration, quantity dispensed, and patient identity. These records are separate from the claim but subject to audit.

Digital treatment notes that capture the administered dose, NDC, and diagnosis at the point of care reduce the rework that comes from incomplete charge entry. Digital intake forms help standardize the clinical data collected before the biller enters the claim.

Modifiers used with J3360

Two modifiers dominate J3360 billing: JW and JZ. Both relate to drug waste reporting, but on different timelines. JW has been mandatory since January 1, 2017, and JZ became mandatory on July 1, 2023. Getting these wrong is one of the most common compliance errors on J-code drug claims.

JW and JZ modifier policy for drug waste reporting

CMS implemented mandatory JW/JZ modifier reporting to improve visibility into drug waste across provider-administered Medicare Part B drugs. The policy applies to single-dose vials where the administered dose may be less than the full vial.

Failing to append either JW or JZ to an applicable Medicare claim can result in claim rejection or a request for additional documentation. CMS has enforced claim rejections for missing JZ since October 1, 2023, and the JW requirement has applied since 2017, so neither modifier carries a grace period today.

For thorough med spa compliance documentation practices that manage injectable drugs, applying this policy consistently across all J-code claims is a billing priority.

Other applicable modifiers may include GY (item or service statutorily excluded from Medicare coverage) and GZ (expected to be denied as not reasonable and necessary). Site-of-service modifiers may also apply, as required by your MAC. Always verify current modifier requirements with the AAPC HCPCS code reference and your MAC’s local coverage policy.

ICD-10 diagnosis codes that support J3360 claims

Medical necessity for diazepam injection must be supported by an appropriate ICD-10 diagnosis code on the claim. The table below lists codes commonly paired with J3360 claims, spanning acute anxiety commonly treated in mental health practices to seizure and muscle spasm management. Verify covered diagnoses against your MAC’s local coverage determination, as coverage policies vary by region.

These codes represent commonly associated diagnoses, not a guarantee of coverage. The MAC makes the final medical necessity determination based on the full clinical record. For seizure presentations, a structured neuro exam cheat sheet standardizes what’s captured in the chart before diazepam is administered. Always verify diagnosis coverage against the applicable LCD before submitting.

NDC codes associated with HCPCS J3360

Multiple manufacturers produce injectable diazepam, and their products each carry a distinct National Drug Code (NDC). CMS requires NDC reporting on Part B drug claims to track drug spend at the product level. The NDC you report must match the specific product you purchased and administered, not a generic crosswalk.

Accurate NDC tracking is particularly important for practices using the inventory management software to track vial-level drug stock and reconcile administered quantities against purchase orders. Using IV therapy intake forms that capture the product NDC at the point of care reduces the chance of a reporting mismatch at claim time.

Both branded Valium and generic diazepam injection products from various manufacturers map to HCPCS Code J3360. The exact NDC list changes as products enter and exit the market. Confirm current NDC-to-HCPCS crosswalk accuracy using the PGM Billing HCPCS lookup tool or the FDA NDC Directory before submission.

Place of service for J3360 billing

The place of service (POS) code affects both the reimbursement rate and the claim’s compliance profile. Diazepam injection is administered across a range of settings, from office-based procedural sedation to hospital outpatient and emergency department visits.

When the sedation itself has no listed anesthesia code, some payers expect it reported separately under CPT Code 01999. The POS code must match the actual setting where the injection was given.

Practices offering IV infusion or injectable drug services, including IV therapy clinic software users, typically bill under POS 11 (office) or POS 22 (outpatient hospital). The correct code depends on their facility registration.

Buy-and-bill process for diazepam (J3360)

The buy-and-bill model means the practice purchases the drug, administers it, and then bills Medicare for reimbursement. For a controlled substance like diazepam, this workflow has more compliance layers than a standard infusion drug.

Practices using an IV therapy EMR can streamline the documentation chain from drug receipt through claim submission. Here is the standard buy-and-bill sequence for HCPCS Code J3360:

1. Acquire the drug. Purchase diazepam injection from an authorized supplier (wholesaler or 340B-qualified source if applicable). Record the NDC, lot number, expiry date, and quantity received in your controlled substance log.
2. Verify medical necessity before administration. Confirm the patient’s diagnosis supports diazepam injection and document the clinical indication in the chart note before the drug is drawn up.
3. Administer and document immediately. Record the exact dose administered (in mg), the route of administration, the time, the administering provider, and any patient response. Note any drug discarded from the vial.
4. Capture charge at the point of care. Enter the HCPCS code J3360, unit count (dose divided by 5 mg), NDC with N4 qualifier, and quantity administered. Flag whether drug waste occurred.
5. Append the correct modifier. JZ if no drug was wasted; JW with a separate waste line if drug was discarded. Both lines must reference the same NDC.
6. Submit the claim. Include at least one ICD-10 diagnosis code supporting medical necessity, the POS code, the NDC, and the modifier. Retain the DEA-compliant administration record and controlled substance log for audit purposes.

The DEA Schedule IV classification means diazepam must be stored in a locked, substantially constructed cabinet and logged per DEA regulations. These documentation obligations run alongside but are separate from Medicare claim requirements.

Related HCPCS codes and crosswalks for J3360

Coders working with diazepam injection claims should know the adjacent codes that may apply in different clinical contexts. Some also serve as fallback codes when a specific product code is unavailable.

Never substitute J3490 (unclassified drugs) for J3360 when diazepam is the drug administered. CMS requires the most specific code available, and J3360 is the specific code for diazepam injection. Using J3490 for a drug that has a designated J-code is a billing error that may trigger a refund request on audit.

How Pabau supports J-code drug billing

Injectable drug billing under J-codes often fails at the documentation-to-claim handoff. The clinical record shows the drug was given, but the charge capture is incomplete, the NDC is missing, or the modifier is wrong. Practice management software like Pabau addresses this by keeping clinical documentation, inventory tracking, and charge capture in the same platform.

Specific features relevant to J3360 and similar J-code drug claims include:

• Digital treatment notes record the administering provider, the exact dose, and the clinical indication. That gives billers what they need to support JW or JZ.
• Prescription management software that creates and transmits the diazepam order, giving billers a digital record of what was prescribed alongside the separate administration note.
• Inventory tracking that logs drug vials received, NDCs, and quantities consumed, supporting the controlled substance documentation requirements for Schedule IV drugs.
• Patient record integration connects the clinical indication to the administered drug. ICD-10 linkage becomes part of the workflow, rather than a separate billing step.

These capabilities help practices that administer injectable drugs across multiple locations. They also help practices handling a mix of Medicare Part B and commercial payer claims for the same drug codes. Practices billing multiple J-code drugs, such as octreotide under HCPCS Code J2354, benefit from the same consolidated record-keeping across every injectable claim.

Manage injectable drug billing without the manual rework

Pabau connects clinical documentation, drug inventory, and charge capture in one workflow. NDCs, administered doses, and drug waste are logged at the point of care. Your biller gets accurate charge data instead of reconstructing it after the fact.

Book a demo

Conclusion

Clean J3360 claims come down to documentation discipline. The dose, the NDC, the diagnosis, and the modifier all need to match before the claim goes out. A practice that captures this at the point of care avoids the slower, costlier path of reconstructing it after a denial.

Pabau’s treatment notes and inventory tracking keep clinical documentation and drug records in one place. The details a clean J3360 claim needs are captured as care happens, rather than rebuilt at billing time. To see how it fits your injectable drug workflow, book a demo with the team.

Continue your research

Managing a practice that administers IV drips or injectables? IV therapy clinic software covers the EMR, scheduling, and billing features built for infusion and injectable drug practices.

Need a reference for injectable drug documentation standards? IV therapy billing practices walks through the documentation, compliance, and charge capture steps that apply across injectable drug administrations.

Looking for a structured approach to controlled substance tracking? Pabau’s inventory management software supports vial-level drug tracking, NDC recording, and quantity reconciliation for Schedule IV and other controlled substances.

Frequently asked questions